Edward Gunther

Edward Gunther, MD is a Professor at Penn State University, affiliated with the College of Medicine and the Department of Medicine under the Division of Hematology and Oncology. He is a key member of the Penn State Cancer Institute and leads research in Next-Generation Therapies.

His research focuses on:

• Carcinogenesis
• Transgenic Mouse Models
• Mammary Tumor Development
• Oncogene Dynamics
• Breast Cancer Progression

Recent publications highlight his work on:

• 2024: Oncogene diversity and reproductive history impacts on premalignant clones
• 2020: Parity-induced protection resistance in breast cancer models
• 2019: Oncogene overdose sensitivity in relapse-proficient subclones
• 2016: Carcinogen-specific Ras-Raf pathway mutations
• 2014: Subclone cooperation in Wnt-driven mammary tumors

Scientific Awards:

• Outstanding Research Publication (2014)

His work has resulted in 29 research outputs and over 2273 citations, with an h-index of 21. He has secured 4 grants from the National Cancer Institute (2024, 2016, 2005, 1999) as Principal/Co-Principal Investigator.